While retatrutide is being developed primarily as an obesity and diabetes treatment, the triple-agonist mechanism has implications beyond weight loss
Gary Foster, chief scientific officer at WeightWatchers Atkins, a WeightWatchers rival, also wants a bite of the lucrative market and has adopted similar language: Were your ally in a new era of weight loss, the low-carb diet program says on a dedicated GLP-1 page on its website
GLP-1 medications were rigorously tested in clinical trials at specific dosages, and the benefits and risks are understood only at these approved doses
If the distribution of confounding factors differs in the two arms, explicative regression analysis will be performed in which the dependent variable will be the normalisation of the serum vitamin B12 concentration, and the independent variable will be the treatment group
One easy-to-swallow tablet per day provides comprehensive antioxidant coverage for both men and women.
Association of sarcopenia with incident osteoporosis: a prospective study of 168,682 UK biobank participants